Literature DB >> 11587204

The stem cell in the pathogenesis and treatment of myelogenous leukemia: a perspective.

M A Lichtman1.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11587204     DOI: 10.1038/sj.leu.2402247

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  Acute myeloid leukemia of donor origin after allogeneic stem cell transplantation from a sibling who harbors germline XPD and XRCC3 homozygous polymorphisms.

Authors:  Hilda Rachel Diamond; Maria Helena Ornellas; Alberto Orfao; Bernadete E Gomes; Mércia M Campos; Teresa S Fernandez; Roberto I da Silva; Gilda Alves; Claudia Lage; Dayse A da Silva; Arthur Moellmann-Coelho; Geydson S da Cruz; Luis Fernando Bouzas; Eliana Abdelhay
Journal:  J Hematol Oncol       Date:  2011-09-27       Impact factor: 17.388

2.  Does a diagnosis of myelogenous leukemia require 20% marrow myeloblasts, and does <5% marrow myeloblasts represent a remission? The history and ambiguity of arbitrary diagnostic boundaries in the understanding of myelodysplasia.

Authors:  Marshall A Lichtman
Journal:  Oncologist       Date:  2013-08-27

3.  Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex Vivo.

Authors:  Katherine L B Knorr; Laura E Finn; B Douglas Smith; Allan D Hess; James M Foran; Judith E Karp; Scott H Kaufmann
Journal:  Stem Cells Transl Med       Date:  2016-11-07       Impact factor: 6.940

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.